These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Safety of moclobemide taken in overdose for attempted suicide. Hetzel W Psychopharmacology (Berl); 1992; 106 Suppl():S127-9. PubMed ID: 1546127 [TBL] [Abstract][Full Text] [Related]
3. Three suicide attempts with moclobemide. Iwersen S; Schmoldt A J Toxicol Clin Toxicol; 1996; 34(2):223-5. PubMed ID: 8618258 [TBL] [Abstract][Full Text] [Related]
4. Serotonin syndrome caused by overdose with paroxetine and moclobemide. FitzSimmons CR; Metha S J Accid Emerg Med; 1999 Jul; 16(4):293-5. PubMed ID: 10417944 [TBL] [Abstract][Full Text] [Related]
5. [Poisoning with a reversible and selective monoaminooxidase inhibitor]. Pall M; Bested KM; Eriksen ND Ugeskr Laeger; 1997 Aug; 159(32):4859-60. PubMed ID: 9273760 [TBL] [Abstract][Full Text] [Related]
6. Serotonin syndrome due to an overdose of moclobemide and clomipramine. A potentially life-threatening association. François B; Marquet P; Desachy A; Roustan J; Lachatre G; Gastinne H Intensive Care Med; 1997 Jan; 23(1):122-4. PubMed ID: 9037653 [TBL] [Abstract][Full Text] [Related]
7. Five fatal cases of serotonin syndrome after moclobemide-citalopram or moclobemide-clomipramine overdoses. Neuvonen PJ; Pohjola-Sintonen S; Tacke U; Vuori E Lancet; 1993 Dec; 342(8884):1419. PubMed ID: 7901695 [No Abstract] [Full Text] [Related]
12. Fatal moclobemide overdose or death caused by serotonin syndrome? Hernandez AF; Montero MN; Pla A; Villanueva E J Forensic Sci; 1995 Jan; 40(1):128-30. PubMed ID: 7876795 [TBL] [Abstract][Full Text] [Related]
13. An uncommon fatality due to moclobemide and paroxetine. Singer PP; Jones GR J Anal Toxicol; 1997 Oct; 21(6):518-20. PubMed ID: 9323537 [TBL] [Abstract][Full Text] [Related]
14. Suicide with moclobemide and perazine. Musshoff F; Varchmin-Schultheiss K; Madea B Int J Legal Med; 1998; 111(4):196-8. PubMed ID: 9646163 [TBL] [Abstract][Full Text] [Related]
15. Safety of moclobemide in clinical use. Chen DT; Ruch R Clin Neuropharmacol; 1993; 16 Suppl 2():S63-8. PubMed ID: 8313399 [TBL] [Abstract][Full Text] [Related]
17. Moclobemide fatalities: report of two cases and analytical determinations by GC-MS and HPLC-PDA after solid-phase extraction. Gaillard Y; Pépin G Forensic Sci Int; 1997 Jun; 87(3):239-48. PubMed ID: 9248042 [TBL] [Abstract][Full Text] [Related]
18. A risk-benefit assessment of moclobemide in the treatment of depressive disorders. Norman TR; Burrows GD Drug Saf; 1995 Jan; 12(1):46-54. PubMed ID: 7741983 [TBL] [Abstract][Full Text] [Related]
19. [Fatal form of serotonin syndrome]. Finge T; Malavialle C; Lambert J Ann Fr Anesth Reanim; 1997; 16(1):80-1. PubMed ID: 9686110 [No Abstract] [Full Text] [Related]
20. Tolerability of moclobemide, a new reversible inhibitor of monoamine oxidase-A, compared with other antidepressants and placebo. Versiani M; Nardi AE; Figueira IL; Stabl M Acta Psychiatr Scand Suppl; 1990; 360():24-8. PubMed ID: 2123366 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]